揭示胶质母细胞瘤的结构规律有望带来更有效的治疗方法
Uncovering rules for aggressive brain tumors could lead to better treatments
研究人员使用单细胞多组学技术和定制计算工具,发现胶质母细胞瘤细胞在不同患者中遵循一致的结构模式。这为开发针对早期细胞状态的靶向治疗提供了新思路。
研究揭示了胶质母细胞瘤的结构规律,为开发针对性治疗提供了新路径。
Aggressive brain tumors follow predictable rules, not chaotic randomness, according to new research. This discovery could lead to new, much-needed ways to treat glioblastoma tumors in the future.
Researchers at the Wellcome Sanger Institute, the European Molecular Biology Laboratory (EMBL), the German Cancer Research Center (DKFZ), the Cancer Research UK Cambridge Institute and their collaborators have mapped over one million cells across glioblastoma tumors. This allowed them to discover that the cancer cells organize themselves according to a consistent, predictable structural pattern across different patients.
In this new study, published Nov. 4 in Nature, the team was able to categorize cancer cells at different stages of their journey within the different environments in glioblastoma tumors. They looked at different time stages and used lab-grown mini tumors to mimic this development.
Along with challenging previously held beliefs about brain tumors, this roadmap opens new paths for developing targeted treatments. As the cancer cells move along in a predictable way during tumor progression, future drugs could specifically target the early developmental-like cells before they transform into harder-to-reach, resistant states.
This work has built a new foundational resource for studies to explore the mechanisms and biology of cancerous brain cells. For example, using the same single-cell multi-omic data, researchers also decoded the gene regulators that drive and restrict glioblastoma cell state transitions, highlighting potential targets that could help avoid treatment resistance. These results are published in a companion paper in Nature. Together these papers unify understanding of the architecture of glioblastomas with insights about cancer cell plasticity, giving a holistic view of this cancer type.
A shifting target for treatment
Glioblastoma is an aggressive form of brain cancer. It is the most common type of brain cancer in adults, with around 3,200 people being diagnosed every year in the U.K. The average survival time for people with glioblastoma is 12 to 18 months, with only 4% of those diagnosed surviving five years or more.
When possible, the most common glioblastoma treatment is surgery, followed by a combination of chemotherapy and radiation therapy. These tumors are difficult to treat due to their location and because many tumors invade multiple parts of the brain, which can make surgery difficult or impossible in some cases. Treatment can also be difficult as these tumors are made up of multiple, highly dynamic cancer cell states that previously did not seem to follow any consistent rules or pattern. This means that treatment might not destroy every cell, leading to drug resistance and cancer re-emergence.
Mapping a shared pattern of tumor growth
In a new study, Sanger Institute researchers and their collaborators used state-of-the-art multi-omic technologies and tailored machine learning computational tools to map multiple sections of brain tumor samples from 12 glioblastoma patients, combining single-cell and spatial atlasing, imaging, and whole-genome sequencing data.
This range of information gives a complete understanding of each cancer cell's molecular state, where it is in the tumor, how it is likely to change over time, how it interacts with the environment around it, and its genetic information. Additionally, the team used samples from multiple regions of the brain tumors to give a full picture of the cells in each tumor section and how they related to each other. The resulting GBM-Space atlas (GBM meaning glioblastoma) is freely accessible.
This allowed the team to see that glioblastoma cells move through the same structural pattern across each patient, following the same rules as the tumor grows:
- Cancer cells in early stages resemble brain stem cells. These developmental-like cells are found at the outer edge of the tumor, known as the leading edge, where the glioblastoma cells start to invade the surrounding healthy brain tissue. These cells act as a pool giving rise to other cancer cell states.
- As the tumor expands, these cells transform into injury response cell states, mimicking cell pathways that are involved in brain tissue repair and wound healing. These injury response cells create an inner structural layer in the tumors.
- In the later stages of brain tumor development, the core of the tumor is cut off from oxygen, meaning that all cell types transition from injury response into severely hypoxic (oxygen-deprived) states.
As well as mapping brain tumor samples, the team developed 3D models of the brain in a dish, known as brain organoids, to validate this tumor roadmap.
Targeting the states tumors may adopt
This research also found that each cancer cell progression stage requires specific immune microenvironments in the tumors. The team suggests that finding ways to interrupt or disrupt these environments could lead to new ways to treat aggressive brain tumors. In the future, new therapeutics could also focus on the gene regulation networks, potentially stopping cell progression, or target the early developmental cells that cannot be easily removed by surgery and often lead to cancer recurrence.
Dr. Richard Mair, co-author at the Cancer Research UK Cambridge Institute and Cambridge University Hospitals NHS Foundation Trust, said, "For too long, we have approached glioblastoma treatment knowing that each patient's tumor contains a complex mixture of cancer cells, but without a clear understanding of how best to target them all. This research gives us an opportunity to think differently. If we can anticipate the different biological states a tumor is likely to adopt, we can begin to develop treatments that target multiple aspects of the disease from the very beginning.
"This could fundamentally change how we design new therapies for glioblastoma, moving toward treatments that are informed not just by what a tumor looks like today, but by what it is likely to become."
Dr. Oliver Stegle, co-senior author of both studies at the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ), said, "Combining unbiased single-cell and multi-omics techniques with tailored computational tools allowed us to go back to the drawing board and challenge long-held assumptions about glioblastoma. We demonstrate that complex but predictable molecular networks govern cancer cell development. This work shows how computational biology can turn massive datasets into meaningful discoveries for patient care."
Dr. Omer Bayraktar, co-senior author of both studies at the Wellcome Sanger Institute and professor at the UCL Cancer Institute, said, "Glioblastoma has evaded understanding for years, despite being one of the most studied types of cancer tumor. By building the largest, multimodal atlas of these tumors to date, we have shown that these tumors are not as chaotic as previously accepted. Instead, they follow a set of rules that can be used to rewrite our understanding of glioblastoma and act as a compass to guide much-needed new treatments in the future."
Publication details
Omer Bayraktar, A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneity, Nature (2026). DOI: 10.1038/s41586-026-11234-8. www.nature.com/articles/s41586-026-11234-8
Moritz Mall, Decoding the regulatory programs governing glioblastoma plasticity, Nature (2026). DOI: 10.1038/s41586-026-11177-0. www.nature.com/articles/s41586-026-11177-0
Journal information: Nature
Key medical concepts
Clinical categories
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Uncovering rules for aggressive brain tumors could lead to better treatments (2026, November 4) retrieved 4 November 2026 from https://medicalxpress.com/news/2026-11-uncovering-aggressive-brain-tumors-treatments.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com